At the news
? BULLISHIMPACT 8/10 8-K filed Feb 26, 2026 at 08:06 ET
Delcath Systems reported strong financial results for Q4 and full year 2025, with full-year revenue up 129% year-over-year to $85.2 million and full-year net income of $2.7 million. The company also issued 2026 guidance calling for at least $100 million in revenue, representing over 17% growth, driven by continued HEPZATO adoption and clinical momentum from positive trial data.
- Full year 2025 revenue was $85.2 million, up 129% from $37.2 million in 2024
- HEPZATO KIT revenue grew to $78.8 million in 2025 from $15.1 million in 2024
- Full year 2025 net income was $2.7 million vs. a net loss of $26.4 million in 2024
- Non-GAAP adjusted EBITDA was $25.1 million in 2025 vs. a loss of $2.5 million in 2024
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access